vs
Amarin Corp plc（AMRN）与华钦科技（CLPS）财务数据对比。点击上方公司名可切换其他公司
华钦科技的季度营收约是Amarin Corp plc的1.8倍（$82.8M vs $45.1M），华钦科技净利率更高（0.2% vs -23.3%，领先23.5%）
Amarin是一家1993年成立的爱裔美籍生物制药企业，总部分别设于爱尔兰都柏林与美国新泽西州布里奇沃特。该企业专注研发及销售心血管疾病治疗药物，已推出处方级Omega-3脂肪酸药物Vascepa（AMR-101）。
华钦科技（CLPS Inc）是全球领先的信息技术咨询与数字化解决方案服务商，核心服务银行、保险、资产管理等金融领域客户，同时覆盖零售、医疗健康、电商等行业，业务遍及北美、亚太及欧洲地区。
AMRN vs CLPS — 直观对比
营收规模更大
CLPS
是对方的1.8倍
$45.1M
净利率更高
CLPS
高出23.5%
-23.3%
损益表 — Q1 FY2026 vs Q4 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $45.1M | $82.8M |
| 净利润 | $-10.5M | $183.0K |
| 毛利率 | — | 23.1% |
| 营业利润率 | 35.5% | 0.2% |
| 净利率 | -23.3% | 0.2% |
| 营收同比 | 7.0% | — |
| 净利润同比 | 33.0% | — |
| 每股收益（稀释后） | — | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AMRNCLPS
| Q2 26 | — | $82.8M | ||
| Q1 26 | $45.1M | — | ||
| Q4 25 | $49.2M | — | ||
| Q3 25 | $49.7M | — | ||
| Q2 25 | $72.7M | — | ||
| Q1 25 | $42.0M | — | ||
| Q4 24 | $62.3M | $71.8M | ||
| Q3 24 | $42.3M | — |
净利润AMRNCLPS
| Q2 26 | — | $183.0K | ||
| Q1 26 | $-10.5M | — | ||
| Q4 25 | $-1.2M | — | ||
| Q3 25 | $-7.7M | — | ||
| Q2 25 | $-14.1M | — | ||
| Q1 25 | $-15.7M | — | ||
| Q4 24 | $-48.6M | $-993.5K | ||
| Q3 24 | $-25.1M | — |
毛利率AMRNCLPS
| Q2 26 | — | 23.1% | ||
| Q1 26 | — | — | ||
| Q4 25 | 47.1% | — | ||
| Q3 25 | 44.7% | — | ||
| Q2 25 | 69.2% | — | ||
| Q1 25 | 59.8% | — | ||
| Q4 24 | -15.4% | 21.9% | ||
| Q3 24 | 38.5% | — |
营业利润率AMRNCLPS
| Q2 26 | — | 0.2% | ||
| Q1 26 | 35.5% | — | ||
| Q4 25 | -12.9% | — | ||
| Q3 25 | -22.4% | — | ||
| Q2 25 | -22.0% | — | ||
| Q1 25 | -39.9% | — | ||
| Q4 24 | -84.3% | -1.3% | ||
| Q3 24 | -59.5% | — |
净利率AMRNCLPS
| Q2 26 | — | 0.2% | ||
| Q1 26 | -23.3% | — | ||
| Q4 25 | -2.5% | — | ||
| Q3 25 | -15.6% | — | ||
| Q2 25 | -19.4% | — | ||
| Q1 25 | -37.4% | — | ||
| Q4 24 | -78.0% | -1.4% | ||
| Q3 24 | -59.4% | — |
每股收益（稀释后）AMRNCLPS
| Q2 26 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | $0.00 | — | ||
| Q3 25 | $-0.02 | — | ||
| Q2 25 | $-0.03 | — | ||
| Q1 25 | $-0.04 | — | ||
| Q4 24 | $-0.12 | — | ||
| Q3 24 | $-0.06 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $307.8M | $29.1M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | — | $57.6M |
| 总资产 | $645.8M | $118.1M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资AMRNCLPS
| Q2 26 | — | $29.1M | ||
| Q1 26 | $307.8M | — | ||
| Q4 25 | $302.6M | — | ||
| Q3 25 | $286.6M | — | ||
| Q2 25 | $298.7M | — | ||
| Q1 25 | $281.8M | — | ||
| Q4 24 | $294.2M | $31.2M | ||
| Q3 24 | $305.7M | — |
股东权益AMRNCLPS
| Q2 26 | — | $57.6M | ||
| Q1 26 | — | — | ||
| Q4 25 | $459.3M | — | ||
| Q3 25 | $458.9M | — | ||
| Q2 25 | $464.9M | — | ||
| Q1 25 | $473.7M | — | ||
| Q4 24 | $486.2M | $63.9M | ||
| Q3 24 | $531.4M | — |
总资产AMRNCLPS
| Q2 26 | — | $118.1M | ||
| Q1 26 | $645.8M | — | ||
| Q4 25 | $670.8M | — | ||
| Q3 25 | $659.8M | — | ||
| Q2 25 | $670.1M | — | ||
| Q1 25 | $655.7M | — | ||
| Q4 24 | $685.3M | $110.0M | ||
| Q3 24 | $750.6M | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AMRN
| U.S | $35.6M | 79% |
| Europe | $4.9M | 11% |
| Rest-of-World (ROW) | $2.8M | 6% |
| Licensing & Royalties | $1.8M | 4% |
CLPS
暂无分部数据
